Download
Sachs_Krämer_et al._Lymphocyte transformation_e.pdf 1,38MB
WeightNameValue
1000 Titel
  • Lymphocyte transformation test: History and current approaches
1000 Autor/in
  1. Sachs, Bernhardt |
  2. Fatangare, Amol |
  3. Sickmann, Albert |
  4. Glassner, Andreas |
1000 Erscheinungsjahr 2021
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-03-18
1000 Erschienen in
1000 Quellenangabe
  • 493:113036
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.jim.2021.113036 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Drug-induced hypersensitivity reactions encompass a variety of different clinical phenotypes ranging from harmless rashes to fatal reactions. They can be classified into allergic (i.e. drug allergy) and non-allergic reactions (i.e. non-allergic hypersensitivity). Drug allergies in turn can either be antibody (e.g. IgE) or T cell-mediated. One of the diagnostic tools for the in vitro detection of drug allergy is the lymphocyte transformation test (LTT) which is based on the activation and expansion of the drug-specific memory T cells following co-incubation of the patient's peripheral mononuclear cells (PMBC) with the suspected drug in vitro. The read-out parameter in the classical LTT is T cell proliferation which can be measured as counts per minute following the addition of radiolabeled thymidine to the cell culture. However, in the course of time different modifications of the classical LTT with regard to the read-out parameters and methods have been proposed. Likewise, variations of the LTT platform itself have been described in the literature. This review article describes the development of the classical LTT and its use in the context of drug allergy detection and summarizes the modifications which have been published over time.
1000 Sacherschließung
lokal Cytokines
lokal Drug allergy
lokal ELISpot
lokal Drug hypersensitivity
lokal Lymphocyte transformation test
lokal ELIS
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2FjaHMsIEJlcm5oYXJkdA==|https://frl.publisso.de/adhoc/uri/RmF0YW5nYXJlLCBBbW9s|https://frl.publisso.de/adhoc/uri/U2lja21hbm4sIEFsYmVydA==|https://frl.publisso.de/adhoc/uri/R2xhc3NuZXIsIEFuZHJlYXM=
1000 Label
1000 Förderer
  1. European Regional Development Fund |
  2. LeitmarktAgentur.NRW |
  3. Bundesinstitut für Arzneimittel und Medizinprodukte |
  4. Leibniz Institute for Analytical Sciences - ISAS |
1000 Fördernummer
  1. -
  2. EFRE-0801755
  3. -
  4. -
1000 Förderprogramm
  1. -
  2. -
  3. -
  4. -
1000 Dateien
  1. Lymphocyte transformation test: History and current approaches
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer European Regional Development Fund |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer LeitmarktAgentur.NRW |
    1000 Förderprogramm -
    1000 Fördernummer EFRE-0801755
  3. 1000 joinedFunding-child
    1000 Förderer Bundesinstitut für Arzneimittel und Medizinprodukte |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer Leibniz Institute for Analytical Sciences - ISAS |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6429522.rdf
1000 Erstellt am 2021-09-28T11:20:13.916+0200
1000 Erstellt von 280
1000 beschreibt frl:6429522
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Thu Nov 11 07:15:17 CET 2021
1000 Objekt bearb. Thu Nov 11 07:14:44 CET 2021
1000 Vgl. frl:6429522
1000 Oai Id
  1. oai:frl.publisso.de:frl:6429522 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source